机构:[1]Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China[2]Tianjin Medical University Cancer Institute and Hospital, Tianjin, China[3]Hebei University, Shijiazhuang, China[4]Shanxi Traditional Chinese Medicine Hospital, Taiyuan, China[5]The First Affiliated Hospital of the Chinese People's Liberation Army General, Beijing, China[6]Affiliated Peace Hospital of Changzhi Medical College, Changzhi, China[7]Shanxi Tumour Hospital, Taiyuan, China[8]Hebei University Hospital, Baoding, China[9]Second People’s Hospital of Datong, Datong, China[10]First People’s Hospital of Yangquan, Yangquan, China[11]The No 1 Hospital of Qinhuangdao Hebei, Qin Huang Dao Hebei, China[12]Peking University Third Hospital, Beijing, China[13]Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China[14]Cangzhou Central Hospital, Cangzhou, China[15]Pekeing University Binhai Hospital, Tianjin, China[16]Xingtai People’s Hospital, Xingtai, China[17]Shanxi Dayi Hospital, Taiyuan, China山西白求恩医院[18]Shanxi University of Traditional Chinese Medicine, Taiyuan, China[19]Yuncheng Central Hospital, Yuncheng, China
第一作者机构:[1]Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China
推荐引用方式(GB/T 7714):
Bai Chunmei,Zhong Diansheng,Zhang Ruixing,et al.Prospective, multicenter, noninterventional and registry clinical study of apatinib in patients with advanced gastric cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2018,36(4):doi:10.1200/JCO.2018.36.4_suppl.137.
APA:
Bai, Chunmei,Zhong, Diansheng,Zhang, Ruixing,Ren, Xiubao,Liu, Likun...&Zhang, Wenzheng.(2018).Prospective, multicenter, noninterventional and registry clinical study of apatinib in patients with advanced gastric cancer.JOURNAL OF CLINICAL ONCOLOGY,36,(4)
MLA:
Bai, Chunmei,et al."Prospective, multicenter, noninterventional and registry clinical study of apatinib in patients with advanced gastric cancer".JOURNAL OF CLINICAL ONCOLOGY 36..4(2018)